Cogent Biosciences, Inc.
COGT
Classement en actions
#3251
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted... Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Prix de l'action
$31.37
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$5.44B
Changement (1 jour)
4.54%
Changement (1 an)
97.81%
Pays
US
Échange Cogent Biosciences, Inc. (COGT)
Catégorie
Healthcare
Nombre d'actions en circulation pour Cogent Biosciences, Inc. (COGT)
Nombre d'actions en circulation au June 2026: 171.01M
Selon les derniers rapports financiers et le cours de l'action de Cogent Biosciences, Inc., le nombre actuel d'actions en circulation est de 171.01M. À la fin de December 2023, l'entreprise avait 79.66M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Cogent Biosciences, Inc. (COGT) de 2015 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 171.01M | 64.66% |
| 2024 | 103.86M | 30.38% |
| 2023 | 79.66M | 35.61% |
| 2022 | 58.74M | 51.66% |
| 2021 | 38.73M | 249.52% |
| 2020 | 11.08M | 45.42% |
| 2019 | 7.62M | 22.43% |
| 2018 | 6.22M | -15.85% |
| 2017 | 7.40M | 26.32% |
| 2016 | 5.86M | 0.00% |
| 2015 | 5.86M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 48.47% |
US
|
|
| 396.00M | 131.57% |
US
|
|
| 478.91M | 180.06% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -63.64% |
NL
|
